Loading…

Role of secreted frizzled-related protein 4 in prediabetes and type 2 diabetes: a cross sectional study

Type 2 diabetes (T2D) has become an epidemic. Delays in diagnosis and as a consequent late treatment has resulted in high prevalence of complications and mortality. Secreted frizzled-related protein 4 (SFRP4), has been recently identified as a potential early biomarker of T2D related to obesity, due...

Full description

Saved in:
Bibliographic Details
Published in:BMC endocrine disorders 2024-06, Vol.24 (1), p.78-10
Main Authors: Sánchez-Pozos, Katy, Granados-Silvestre, M A, Nieto-Velázquez, N G, Mejía-Blanquel, María Alicia, Galicia-Martínez, Natsyelli, Mandujano-Cerón, Jessica, Jaimes-Santoyo, Joel, Ortiz-López, María Guadalupe
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Type 2 diabetes (T2D) has become an epidemic. Delays in diagnosis and as a consequent late treatment has resulted in high prevalence of complications and mortality. Secreted frizzled-related protein 4 (SFRP4), has been recently identified as a potential early biomarker of T2D related to obesity, due to its association with low grade inflammation in adipose tissue and impaired glucose metabolism. We aimed to evaluate the role of SFRP4 in prediabetes and T2D in a Mexican population. This was a cross-sectional study that included 80 subjects with T2D, 50 subjects with prediabetes and 50 healthy individuals. Fasting SFRP4 and insulin concentrations were measured by ELISA. Human serum IL-10, IL-6, IL-1β and IL-8 levels were quantified by flow cytometry. Genotyping was performed by TaqMan® probes. Prediabetes and T2D patients had significantly higher SFRP4 levels than controls (P 
ISSN:1472-6823
1472-6823
DOI:10.1186/s12902-024-01613-5